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A red-necked male wallaby (Macropus rufogriseus) from a German zoo was presented for acute onset of severe neurological
signs, including head tremor, lethargy, unresponsiveness, and weakness. Serum biochemical abnormalities included increased
LDH- and AST-levels, hyperproteinaemia, and reduced ALT-, ALP-, and creatinine-levels. The wallaby was found serologically
positive for Toxoplasma gondii by the indirect haemagglutination test. After initiation of therapy by subcutaneous injections of
trimethoprim/sulfadoxin, amelioration of neurological signs was noted and after 10 days the aﬀected wallaby recovered. T. gondii
can be conﬁrmed rapidly by serology, and immediate therapy may reduce clinical illness and fatality of the disease within captive
macropods.
Toxoplasma gondii infections underlie complex immunolog-
ical regulations, and clinical disease is generally limited to
naive, immature, or immunosuppressed animals [1]. How-
ever, in adult Australian marsupials, particularly macropods
(Macropodidae), toxoplasmosis can cause high morbidity
and mortality [2]. Wallabies are reported as the most
susceptible in this family [3]. Fatal generalized toxoplasmosis
in red-necked wallabies (Macropus rufogriseus)h a sb e e n
reported recently [4, 5]. In this report, we describe a case
of presumptive acute toxoplasmosis with a history of neu-
rological signs, in a captive red-necked wallaby (Macropus
rufogriseus) from the zoo of Hamm.
In September 2007, an 8.5-year-old red-necked male
wallaby (Macropus rufogriseus) displaying severe neurologi-
cal signs, including head tremor, lethargy, unresponsiveness,
and weakness (see Figure 1) was presented to the veterinary
surgeon of the Zoo of Hamm, (59065, Germany). Physical
examination revealed pyrexia (39◦C), neurological and oph-
thalmic signs including nystagmus and bilateral epiphora.
Serum biochemical abnormalities included increased LDH-
andAST-levels,hyperproteinaemia,andreducedALT-,ALP-,
and creatinine-levels. Despite immediate supportive ther-
apy with antibiotics (enroﬂoxacin, 10mg/kg body weight,
s.c., Baytril, Bayer) and corticosteroids (dexamethasone,
0.1mg/kgbodyweight,s.c.,Medistar-Dexamethason,Medis-
tar), there was no improvement. After one week of stag-
nation, a tentative diagnosis of toxoplasmosis was made.
For conﬁrmation, blood samples were taken for serologi-
cal analysis. The wallaby was found serologically positive
for T. gondii, showing high antibody titres (≥1:1024)
in the indirect haemagglutination (IHA) test (Cellognost-
Toxoplasmosis H, Dade Behring). Neither T. gondii- nor
Neospora caninum-DNA was detected in the EDTA-blood
samples by speciﬁc PCR [6].
After conﬁrmation of toxoplasmosis, appropriate treat-
ment of the wallaby was initiated. Subcutaneous injections
of trimethoprim/sulfadoxin (15mg/kg body weight daily for
10days,Sulphix,Bela-Pharm)wereadministered.Threedays
after initiation of therapy, amelioration of neurological signs
was noted in the wallaby and after 7 days the majority of the
clinical signs wereno longerapparent. As the infectedanimal
shared premises with two other wallabies and T. gondii2 Veterinary Medicine International
Figure 1: Red-necked wallaby (Macropus rufogriseus) showing
lethargy and severe weakness as indicated by the inability to keep
its head upright.
infection of these could not be excluded, respective blood
samples were analysed serologically as well. Both wallabies,
which showed no clinical signs of disease, also had high
antibody titres (≥1:1024) against T. gondii.
Toxoplasmosis has been reported in captive macropods
f r o mv a r i o u sz o o sw o r l d w i d e[ 5, 7]. As red-necked walla-
bies (Macropus rufogriseus) are herbivores, they presumably
acquire T. gondii by the oral uptake of sporulated oocysts
shed from stray cats or other felids [7]. Transplacental and
transmammary infections are also reported in joeys [3]. In
red-necked wallabies, generalized T. gondii infections may be
associated with nonsuppurative meningoencephalitis, hep-
atitis, myositis, myocarditis, keratitis, uveitis, choroidoretini-
tis, endophthalmitis, or severe enteritis [5]. As such, a broad
range of clinical signs, such as depression, lethargy, ataxia,
cataracts,unresponsiveness,weakness,diarrhoea,andweight
loss have been described. The neurological ﬁndings seen in
this report, such as depression, nystagmus, and head tremor
may reﬂect an acute meningoencephalitis, bilateral epiphora,
and ophthalmic disorders. Serum biochemical abnormalities
detected in the sick wallaby, such as hyperproteinaemia,
couldalsoindicateaninﬂammatoryprocess.IncreasedLDH-
levelsareoftenseeninmyositis/myocarditis,whichhavebeen
reported in acute toxoplasmosis in wallabies [5]. Subclinical
T. gondii infections,asreportedintheotherspecies,havealso
been documented in macropods [8, 9]. Acute toxoplasmosis
in this wallaby might have been triggered by individual addi-
tional factors, for example, stress. The wallaby mentioned in
this report most probably became infected by the ingestion
ofsporulated oocystsof T. gondii spreadon thegroundofthe
premises.Interestingly,thepremisesﬂankedalocalallotment
gardenareawithastablestraycatpopulation.Formanyyears
stray cats have been observed at the Zoo of Hamm and, as in
other zoos, they are suspected to be the most likely source of
T. gondii-oocysts contamination [7].
The case reported here indicates that toxoplasmosis
should be considered as a diﬀerential diagnosis in cases of
neurological disorders in wallabies. T. gondii infection can be
conﬁrmed rapidly by serology, and immediate therapy may
reduceclinicalillnessandfatalityofthediseasewithincaptive
macropods. The treatment with trimethoprim/sulfonamide
has been described to be eﬀective against T. gondii and may
be used prophylactically in macropods during toxoplasmosis
outbreaks [10]. Additionally, the successful treatment with
atovaquone in wallabies suﬀering from ocular toxoplasmosis
has recently been described [11].
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